{
  "zip": "2860",
  "sector": "Healthcare",
  "fullTimeEmployees": 329,
  "longBusinessSummary": "Zealand Pharma A/S, a biotechnology company, engages in the discovery and development of peptide-based medicines in Denmark. It has a portfolio of medicines in development stage focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes glepaglutide, a long acting GLP-2 analog, which is in Phase 3 clinical trials for the treatment of short bowel syndrome; and dasiglucagon, a stable glucagon analog for the treatment of severe hypoglycemia in diabetes and congenital hyperinsulinism, as well as for use in dual-hormone artificial pancreas for automated diabetes management. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; and Beta Bionics, Inc. to initiate home-use trial of the iLet bionic pancreas with dasiglucagon for autonomous bihormonal treatment of type 1 diabetes, as well as research agreement with Orbit Discovery Ltd. and Torrey Pines Institute for Molecular Studies. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.",
  "city": "Copenhagen",
  "phone": "45 88 77 36 00",
  "country": "Denmark",
  "companyOfficers": [],
  "website": "http://www.zealandpharma.com",
  "maxAge": 1,
  "address1": "Sydmarken  11",
  "fax": "45 88 77 38 98",
  "industry": "Biotechnology",
  "address2": "SOeborg",
  "previousClose": 35.95,
  "regularMarketOpen": 35.99,
  "twoHundredDayAverage": 36.73104,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 35.95,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 35.95,
  "fiftyDayAverage": 35.95,
  "trailingAnnualDividendRate": null,
  "open": 35.99,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.005617,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 35.95,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 700,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1518743680,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 31,
  "priceToSalesTrailing12Months": null,
  "dayLow": 35.95,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 700,
  "fiftyTwoWeekHigh": 43.05,
  "forwardPE": -24.127518,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 24.6,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 35.95,
  "exchange": "PNK",
  "shortName": "ZEALAND PHARMA AS",
  "longName": "Zealand Pharma A/S",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ZLDPF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_1268514",
  "uuid": "75d75b05-2fd0-3f4f-b97d-a0e26af16850",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -2.18894,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": -1.49,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 39735500,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.58649,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.00103,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 30581937,
  "enterpriseValue": 1427744768,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 35.99,
  "logo_url": "https://logo.clearbit.com/zealandpharma.com"
}